ARDT
Income statement / Annual
Last year (2024), Ardent Health Partners, LLC's total revenue was $5.97 B,
an increase of 10.29% from the previous year.
In 2024, Ardent Health Partners, LLC's net income was $210.34 M.
See Ardent Health Partners, LLC,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$5.97 B |
$5.41 B |
$5.13 B |
$4.87 B |
$4.16 B |
$3.00 B |
$2.11 B |
$2.03 B |
| Cost of Revenue |
$1.03 B
|
$140.84 M
|
$955.17 M
|
$927.33 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$4.93 B
|
$5.27 B
|
$4.17 B
|
$3.94 B
|
$4.16 B
|
$3.00 B
|
$2.11 B
|
$2.03 B
|
| Gross Profit Ratio |
0.83
|
0.97
|
0.81
|
0.81
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$15.70 M
|
$19.90 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$3.88 B
|
$3.61 B
|
$3.37 B
|
$3.13 B
|
$2.68 B
|
$407.99 M
|
$1.38 B
|
$244.37 M
|
| Selling & Marketing Expenses |
$0.00
|
$14.87 M
|
$0.00
|
$0.00
|
$0.00
|
$758.74 M
|
$566.97 M
|
$72.92 M
|
| Selling, General & Administrative Expenses |
$3.88 B
|
$3.62 B
|
$3.37 B
|
$3.13 B
|
$2.68 B
|
$1.17 B
|
$1.95 B
|
$1.81 B
|
| Other Expenses |
$642.51 M
|
$1.42 B
|
$585.81 M
|
$374.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$4.53 B
|
$5.04 B
|
$3.96 B
|
$3.51 B
|
$4.08 B
|
$2.77 B
|
$2.11 B
|
$1.81 B
|
| Cost And Expenses |
$5.56 B
|
$5.18 B
|
$4.91 B
|
$4.43 B
|
$4.02 B
|
$2.88 B
|
$2.02 B
|
$1.90 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$65.58 M
|
$65.43 M
|
$82.05 M
|
$93.83 M
|
$108.60 M
|
$70.74 M
|
$26.95 M
|
$63.99 M
|
| Depreciation & Amortization |
$146.29 M
|
$140.84 M
|
$138.17 M
|
$137.20 M
|
$143.19 M
|
$109.53 M
|
$71.51 M
|
$89.88 M
|
| EBITDA |
$574.93 M |
$350.00 M |
$531.70 M |
$526.93 M |
$245.75 M |
$230.91 M |
$142.83 M |
$213.80 M |
| EBITDA Ratio |
0.1
|
0.06
|
0.1
|
0.11
|
0.06
|
0.08
|
0.07
|
0.11
|
| Operating Income Ratio |
0.07
|
0.04
|
0.04
|
0.09
|
0.04
|
0.04
|
0.04
|
0.06
|
| Total Other Income/Expenses Net |
-$42.70 M
|
-$77.89 M
|
$94.45 M
|
-$140.68 M
|
-$264.37 M
|
-$71.13 M
|
-$40.38 M
|
-$81.23 M
|
| Income Before Tax |
$363.06 M
|
$151.61 M
|
$311.48 M
|
$295.89 M
|
-$114.62 M
|
$50.64 M
|
$44.37 M
|
$44.80 M
|
| Income Before Tax Ratio |
0.06
|
0.03
|
0.06
|
0.06
|
-0.03
|
0.02
|
0.02
|
0.02
|
| Income Tax Expense |
$63.35 M
|
$22.64 M
|
$46.11 M
|
$51.31 M
|
-$11.29 M
|
$49.87 M
|
$8.02 M
|
$63.93 M
|
| Net Income |
$210.34 M
|
$50.29 M
|
$188.91 M
|
$154.26 M
|
-$143.02 M
|
-$35.65 M
|
$14.60 M
|
-$46.36 M
|
| Net Income Ratio |
0.04
|
0.01
|
0.04
|
0.03
|
-0.03
|
-0.01
|
0.01
|
-0.02
|
| EPS |
1.59 |
0.35 |
1.32 |
1.08 |
-1.01 |
-0.25 |
0.1 |
-0.33 |
| EPS Diluted |
1.58 |
0.35 |
1.32 |
1.08 |
-1.01 |
-0.25 |
0.1 |
-0.33 |
| Weighted Average Shares Out |
$132.44 M
|
$143.26 M
|
$143.26 M
|
$143.26 M
|
$140.96 M
|
$140.96 M
|
$140.96 M
|
$140.96 M
|
| Weighted Average Shares Out Diluted |
$132.75 M
|
$143.26 M
|
$143.26 M
|
$143.26 M
|
$140.96 M
|
$140.96 M
|
$140.96 M
|
$140.96 M
|
| Link |
|
|
|
|
|
|
|
|
